Literature DB >> 16027727

Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development.

Heather A Steinman1, Kathleen M Hoover, Marilyn L Keeler, Arthur T Sands, Stephen N Jones.   

Abstract

The Mdm2 and Mdm4 genes are amplified and overexpressed in a variety of human cancers and encode structurally related oncoproteins that bind to the p53 tumor suppressor protein and inhibit p53 activity. Mice deleted for either Mdm2 or Mdm4 die during embryogenesis, and the developmental lethality of either mouse model can be rescued by concomitant deletion of p53. However, the phenotypes of Mdm2 and Mdm4-deficient mice suggest that Mdm2 and Mdm4 play nonoverlapping roles in regulating p53 activity during development, with Mdm2 regulating p53-mediated cell death and Mdm4 regulating p53-mediated inhibition of cell growth. Here, we describe complete rescue of Mdm4-deficient mice by expression of an Mdm2 transgene, and demonstrate that Mdm2 can regulate both p53-mediated apoptosis and inhibition of cell growth in the absence of Mdm4 in primary cells. Furthermore, deletion of Mdm4 enhances the ability of Mdm2 to promote cell growth and tumor formation, indicating that Mdm4 has antioncogenic properties when Mdm2 is overexpressed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027727     DOI: 10.1038/sj.onc.1208930

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.

Authors:  Chuandong Fan; Xinjiang Wang
Journal:  Cell Cycle       Date:  2017-02-06       Impact factor: 4.534

2.  The Roles of MDM2 and MDMX Phosphorylation in Stress Signaling to p53.

Authors:  Jiandong Chen
Journal:  Genes Cancer       Date:  2012-03

3.  It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.

Authors:  Ian M Love; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-03

Review 4.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 5.  MdmX regulates transformation and chromosomal stability in p53-deficient cells.

Authors:  Zdenka Matijasevic; Anna Krzywicka-Racka; Greenfield Sluder; Stephen N Jones
Journal:  Cell Cycle       Date:  2008-10-15       Impact factor: 4.534

6.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

7.  A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.

Authors:  Diptee A Kulkarni; Alexei Vazquez; Bruce G Haffty; Elisa V Bandera; Wenwei Hu; Yvonne Y Sun; Deborah L Toppmeyer; Arnold J Levine; Kim M Hirshfield
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

8.  Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity.

Authors:  B Bardot; R Bouarich-Bourimi; J Leemput; V Lejour; A Hamon; L Plancke; A G Jochemsen; I Simeonova; M Fang; F Toledo
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

9.  MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.

Authors:  Zdenka Matijasevic; Heather A Steinman; Kathleen Hoover; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

Review 10.  The Roles of MDM2 and MDMX in Cancer.

Authors:  Orit Karni-Schmidt; Maria Lokshin; Carol Prives
Journal:  Annu Rev Pathol       Date:  2016-03-17       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.